Musi waChikumi 29, 2017, kuvandudzwa kwaLaipushiutai, kirasi yandinosimudzira mushonga wekushandira pamwe nejenyumed neGuangzhou Linkelth Mechi Kuzivisa kwezvinodhaka kwakadikanwa kwakagamuchirwa neCFDA.

Jymed And Guangzhou Linked Linkelal Medial Medial Medical Comnology CO., LTD Mhando dzakapedza Poc Clinical fundo muEU uye yakawana kuchengetedzwa kwakanaka uye kudzorera mitengo. Zvese zviri zviviri FDA uye EMAZE inoziva kuti mhando dzinogona kuiswa kurapwa pane i / II Line, uye yekutanga ichipiwa kune varwere vane mwero yeColitis mumiedzo yekiriniki yeCFDA.

UlCerative Colitis (UC) ipfungwa isingaperi, isina-chaiyo yekuzvidza inoitika mu rectum nekoroni. Sekureva kwehuwandu, huwandu hwehukwana hweUC ndeye 1.2 kusvika ku20.3 Money / 100,000 munhu pagore uye kuwanda kweUC ndeye 7.6 kusvika 246,0 kesi / zviuru gumi zvemakore. Chiitiko cheUC chakajairika muvakuru vechidiki. Iyo UC musika ine chiyero chakakura uye chinoda zvezvinodhaka, uye zvicharamba zvichichengetedza kukura kwakanyanya mune ramangwana. Parizvino, UC yekutanga-mutsara zvinodhaka inonyanya kubva paMesalazine uye mahormone, uye yechipiri-mishonga inosanganisira immunosupppress uye biological menoclonal antibodies. Mesalaazine ine vhoriyamu yekutengesa yeChina uye US $ 2 bhiriyoni muUnited States muna 2015 Iyo ine yakanaka musika mukana uye inotarisirwa kuve yekutanga-mutsara uc drug.